Global laws, regulations, guidelines, and guidances govern prescription biopharmaceutical and device product development, approval, and maintenance. DIA provides a unique forum that encourages open dialogue among regulators and other thought leaders to discuss challenges around global regulations and their impact on development strategies, global harmonization, and convergence to improve the practice of regulatory affairs.
Learning
DIA Digital Learning Catalog
DIA Learning programs provide unique, realistic opportunities for professionals to learn best practices in their fields with Internet-based courseware, conveniently accessible anytime, anywhere.
Regulatory Affairs Community
Regulatory Affairs Professionals connect to share non-proprietary global information and best practices for new and emerging regulatory requirements in the development and commercialization of healthcare treatments. Working groups include CMC, Labeling, AdPromo, Regulatory Intelligence, and Regulatory Information Management.